Sort
11,323 grants matching “glioblastoma”
Designing cancer-inspired scaffolds for neural repair
$191,060Robert Chase Cornelison · University Of Massachusetts Amherst · R21 · FY2021 · EB
Targeting abnormal immunomechanics in the glioblastoma microenvironment to improve therapeutic response
$191,052Meenal Datta · University Of Notre Dame · K22 · FY2021 · CA
Targeting abnormal immunomechanics in the glioblastoma microenvironment to improve therapeutic response
$191,052Meenal Datta · University Of Notre Dame · K22 · FY2023 · CA
Targeting abnormal immunomechanics in the glioblastoma microenvironment to improve therapeutic response
$191,052Meenal Datta · University Of Notre Dame · K22 · FY2022 · CA
Clinical and Molecular Studies of Novel Therapeutics in Malignant Brain Tumors
$191,011Tracy T Batchelor · Massachusetts General Hospital · K24 · FY2011 · CA
Identification of glioma tumor-initiating cells
$190,902Michael K Cooper · Vanderbilt University · R21 · FY2011 · NS
Biostatistics and Bioinformatics Core
$190,895James E Herndon · Duke University · P01 · FY2019 · CA
Targeting the PI3 pathway in Gliomas with PI3 inhibitors and rational combination
$190,893W K Alfred Yung · University Of Tx Md Anderson Can Ctr · P50 · FY2008 · CA
Myeloid Recruitments and their Role in Brain Tumors
$190,772Dolores Hambardzumyan · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · NS
The Role of ING4 in Modulating the Tumorigenic Contribution of NF-kB in Gliomas
$190,729Etty N. Benveniste · University Of Alabama At Birmingham · R21 · FY2007 · NS
GENETIC ANALYSIS OF HUMAN GLIOMAS
$190,667Roswell Park Cancer Institute Corp · R01 · FY2000 · CA
Characterizing and Targeting Tumoral Factors Recruiting Perivascular Progenitors
$190,656Manish Aghi · University Of California, San Francisco · K02 · FY2012 · NS
Characterizing and Targeting Tumoral Factors Recruiting Perivascular Progenitors
$190,656Manish Aghi · University Of California, San Francisco · K02 · FY2013 · NS
Examining the Role of a Novel Long Noncoding RNA, linc02454, in Resistance of Glioblastoma to Temozolomide
$190,648Frank Attenello · University Of Southern California · K08 · FY2024 · NS
Slow cycling cell RNA based T cell therapy to prevent recurrence in GBM
$190,625Loic Pierre Deleyrolle · University Of Florida · R21 · FY2021 · NS
Regulation of the Tumor Immune Cell Landscape by Ciliated Glioblastoma Cells
$190,625Matthew Robert Sarkisian · University Of Florida · R21 · FY2024 · NS
MOUSE MODELS FOR EXPLORING THE DEVELOPMENTAL ORIGINS OF SEX DIFFERENCES IN GLIOBLASTOMA
$190,625Joshua B Rubin · Washington University · R21 · FY2016 · NS
Targeting SREBP-1 regulated fatty acid synthesis pathway to treat glioblastoma
$190,625Deliang Guo · Ohio State University · R21 · FY2011 · NS
Triple Anti-Angiogenic Therapy for Brain Tumors
$190,620W K Alfred Yung · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA
Designing cancer-inspired scaffolds for neural repair
$190,465Robert Chase Cornelison · University Of Massachusetts Amherst · R21 · FY2022 · EB
PVSRIPO in melanoma
$190,389Georgia Beasley · Duke University · K08 · FY2023 · CA
Differentiation of Glioma from Radiation Injury Using Cellular MRI
$190,313Ali Syed Arbab · Henry Ford Health System · R21 · FY2007 · NS
Biologic consequence and therapeuticimplications of cysteine catabolism in glioblastoma
$190,000Prakash Chinnaiyan · William Beaumont Hospital Research Inst · R21 · FY2016 · NS
Clinical and Molecular Studies of Novel Therapeutics in Malignant Brain Tumors
$189,955Tracy T Batchelor · Massachusetts General Hospital · K24 · FY2010 · CA
Examining the role of XRN2 in radio and chemo-resistance
$189,934Julio Cesar Morales · University Of Oklahoma Hlth Sciences Ctr · P20 · FY2022 · GM